| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/26/2011 | WO2011041300A4 Reduced-odor polyol composition and method of producing same |
| 05/26/2011 | WO2011039388A3 3-indazolyl ether family with cannabinoid and/or cholinergic properties |
| 05/26/2011 | WO2011039308A3 Gluten-free foodstuff |
| 05/26/2011 | WO2011037712A3 Nutritional compositions including theanine and exogenous nucleotides |
| 05/26/2011 | WO2011016395A8 Preparation for oral cavity |
| 05/26/2011 | WO2011005609A3 Imaging gastrointestinal volumes and motility |
| 05/26/2011 | WO2010148314A3 Preparation of esomeprazole and its pharmaceutically acceptable salts |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110124735 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 05/26/2011 | US20110124718 Reduction Of Acetaminophen Toxicity By Dietary Milk Thistle Extract |
| 05/26/2011 | US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124687 Pharmaceutical composition |
| 05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/26/2011 | US20110124677 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 05/26/2011 | US20110124672 Thienyl Compounds |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124670 Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis |
| 05/26/2011 | US20110124667 Methods for the treatment of irritable bowel syndrome |
| 05/26/2011 | US20110124664 Polycationic Compounds And Uses Thereof |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124644 Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110124594 Compositions that aim to promote the development and growth of a beneficial vaginal microflora |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124579 Sialic acid to support salivation |
| 05/26/2011 | US20110124563 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
| 05/26/2011 | US20110123692 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 05/26/2011 | US20110123648 Use of coconut water extract or coconut shell extract for treating immunological diseases and/or disorders |
| 05/26/2011 | US20110123640 Novel fermented milk product and use thereof |
| 05/26/2011 | US20110123634 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123633 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123628 Rare earth metal compounds, methods of making, and methods of using the same |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123605 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123599 Aroma therapy patch |
| 05/26/2011 | US20110123576 Intestinal environment-improving agent |
| 05/26/2011 | US20110123547 Compounds Having CRTH2 Antagonist Activity |
| 05/26/2011 | US20110123495 Derivatives of pyridone and use thereof |
| 05/26/2011 | US20110123480 Chimeric proteins and uses thereof |
| 05/26/2011 | US20110123461 Compositions and Methods for the Maintenance of Oral Health |
| 05/26/2011 | US20110123460 Pharmaceutical formulation for treating the upper digestive tract |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | CA2781384A1 Biofilm disruptive compositions |
| 05/26/2011 | CA2778301A1 Compositions for treating centrally mediated nausea and vomiting |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2324852A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324849A2 Selective immune down regulation (SIDR) mediated transplantation processes |
| 05/25/2011 | EP2324840A1 Production of caffeoylquinic acids from plant cell cultures of echinacea angustifolia |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324833A1 Film preparation containing loperamide hydrochloride |
| 05/25/2011 | EP2324826A1 Hydrophilic amino acid-containing preparation having improved taste |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324812A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/25/2011 | EP2324046A2 Tgr5 modulators and methods of use thereof |
| 05/25/2011 | EP2324019A1 A crystalline form of 4-(5-{(ir)-1-[5- (3-chlorophenyl) isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl) pyridine |
| 05/25/2011 | EP2324015A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 05/25/2011 | EP2323970A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 05/25/2011 | EP2323679A2 Clip inhibitors and methods of modulating immune function |
| 05/25/2011 | EP2323674A2 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 05/25/2011 | EP2323669A1 Arabinoxylans for modulating the barrier function of the intestinal surface |
| 05/25/2011 | EP2323658A1 A new crystalline form of 4-(5-{ (ir)-1-[5-(3- chlorophenyl) isoxazol-3-yl]ethoxy}-4-methyl-4h-l, 2, 4-triazol-3-yl) pyridine |
| 05/25/2011 | EP2082750B1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 05/25/2011 | EP1439847B1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1374902B1 Anti-AILIM antibodies for the treatment of Crohn's disease |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1325112B1 Methods of isolating bipotent hepatic progenitor cells |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1966036B Chinese medicine for treating gastrointestinal disease and preparation method thereof |
| 05/25/2011 | CN1813872B Liver-reinforcing and toxin-dispelling capsule for treating heptitis B and its preparing process |
| 05/25/2011 | CN1785180B Method for detecting compound bismuth potassium citrate metronidazole |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102071239A Anti-tumor mung bean polypeptide, preparation method thereof and application thereof to tumors |
| 05/25/2011 | CN102070726A Method for safely extracting cordyceps sinensis polysaccharide |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070699A Trihydroxy-substituted pentacyclic triterpene compounds and preparation method and application thereof |
| 05/25/2011 | CN102070691A Metacavir crystal form, preparation method thereof and medicinal composition containing metacavir crystal form |
| 05/25/2011 | CN102070670A Purine derivatives for treating hepatitis B and preparation method and application thereof |
| 05/25/2011 | CN102068707A Traditional Chinese medicine contrast medium adjuvant used for B ultrasonic and preparation method thereof |
| 05/25/2011 | CN102068682A Chinese medicinal composition for treating digestive system diseases and preparation method thereof |
| 05/25/2011 | CN102068680A Omphaloidean external medicament for treating enteritis and preparation method thereof |
| 05/25/2011 | CN102068678A Traditional Chinese medicine for treating gastropathy |
| 05/25/2011 | CN102068677A Chinese medicament for treating spleen and stomach deficiency-cold |
| 05/25/2011 | CN102068675A Traditional Chinese medicine composition for treatment of chronic diarrhoea and preparation method thereof |
| 05/25/2011 | CN102068674A Chinese medicinal composition for treating chronic diarrhea and preparation method thereof |
| 05/25/2011 | CN102068673A Quality control method of stomach-strengthening and chest-relieving pill as Chinese herbal preparation |
| 05/25/2011 | CN102068669A Medicament for treating infant hepatitis syndrome, and preparation method and quality control method thereof |
| 05/25/2011 | CN102068666A Traditional Chinese medicine for treatment of gastric disease |
| 05/25/2011 | CN102068662A Traditional Chinese medicine formula for treatment of achalasia of esophagus cardia |
| 05/25/2011 | CN102068658A Chinese medicine composite for clearing heat, detoxicating, dispelling dampness and eliminating stagnation and preparation method thereof |
| 05/25/2011 | CN102068655A Quality control method for liver-soothing qi-regulating pill as traditional Chinese preparation |
| 05/25/2011 | CN102068653A Medicament for preparing Tibetan medicament preparation for treating liver diseases |
| 05/25/2011 | CN102068652A Traditional Chinese medicine for treating infantile diarrhea |